Journals / Kocaeli Tıp Dergisi / 2021 / Cilt: 10 - Sayı: Ek 1

Age of Pandemics: WillWe Be Ableto Perform Gastrointestinal Cancer Surgical Treatments in Future Pandemics? What have we Learned from the COVID-19 Pandemic in Our Country, Which is one of the Developing Countries?

Pandemi Çağı: Gelecekteki Pandemilerde Gastrointestinal Kanser Cerrahi Tedavileri Uygulayabilecek Miyiz? Gelişmekte Olan Ülkelerden Biri Olan Ülkemizde COVID-19 Pandemisinden Neler Öğrendik?

Pages
103–111
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

DISCUSSION AND CONCLUSION: In this study, no overall increase in morbidity and mortality was observed in gastrointestinal cancer surgeries during COVID-19 period, except increased pulmonary complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: The pandemic caused by the Covid 19 virus, announced on March 11 2020 has affected the treatment regimen of oncology patients all over the world.
📊
Key Findings & Data:METHODS: The study was designed in 2 groups, covering the 6 months before and after the pandemic start date (prepandemic and pandemic period).
💡
Conclusion & Impact:DISCUSSION AND CONCLUSION: In this study, no overall increase in morbidity and mortality was observed in gastrointestinal cancer surgeries during COVID-19 period, except increased pulmonary complications.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: The pandemic caused by the Covid 19 virus, announced on March 11 2020 has affected the treatment regimen of oncology patients all over the world. In this study, we aimed to determine the effects of the pandemic on the surgical treatment of cancer patients and to make this experience a guide for future pandemics. METHODS: The study was designed in 2 groups, covering the 6 months before and after the pandemic start date (prepandemic and pandemic period). In addition, the pandemic period was divided into two groups according to the starting time of the use of the Polymerase Chain Reaction test for preoperative screening. A total of 218 patients older than 18 years of age, who underwent resection with the diagnosis of gastrointestinal cancer and without preoperative upper respiratory tract symptoms were included to the study. RESULTS: There was no significant difference in demographic characteristics between the groups, except for the increase in neoadjuvant therapy during the pandemic period (p: 0.029) and the general complication rate was not statistically significant (p=0.327). However, in the subgroup analysis of complications, it was observed that pulmonary complications developed more frequently during the pandemic period (p= 0.000). DISCUSSION AND CONCLUSION: In this study, no overall increase in morbidity and mortality was observed in gastrointestinal cancer surgeries during COVID-19 period, except increased pulmonary complications. At the same time, it was observed that the routine application of the COVID-19 PCR test before surgery did not cause any statistical change in the results.

Özet

GİRİŞ ve AMAÇ: 11 Mart 2020'de açıklanan Covid 19 virüsünün neden olduğu pandemi, tüm dünyada onkoloji hastalarının tedavi rejimini etkiledi. Bu çalışmada pandeminin kanser hastalarının cerrahi tedavisine etkilerini belirlemeyi ve bu deneyimi gelecekteki pandemiler için bir rehber haline getirmeyi amaçladık. YÖNTEM ve GEREÇLER: Çalışma, pandemi başlangıç tarihinden 6 ay öncesi ve sonrasını (pandemi öncesi ve pandemi dönemi) kapsayan 2 grup halinde tasarlanmıştır. Ayrıca pandemi dönemi, Polimeraz Zincir Reaksiyon testinin ameliyat öncesi taramaya başlama zamanına göre iki gruba ayrıldı. Gastrointestinal kanser tanısı ile rezeksiyon uygulanan ve ameliyat öncesi üst solunum yolu semptomları olmayan 18 yaş üstü toplam 218 hasta çalışmaya dahil edildi. BULGULAR: Pandemik dönemde neoadjuvan tedavideki artış (p: 0,029) dışında gruplar arasında demografik özellikler açısından anlamlı farklılık yoktu ve genel komplikasyon oranı istatistiksel olarak anlamlı değildi (p = 0,327). Ancak komplikasyonların subgrup analizinde pandemi döneminde pulmoner komplikasyonların daha sık geliştiği görüldü (p = 0.000). TARTIŞMA ve SONUÇ: Bu çalışmada COVID-19 döneminde gastrointestinal kanser ameliyatlarında artan pulmoner komplikasyonlar dışında genel morbidite ve mortalite artışı gözlenmemiştir. Aynı zamanda COVID-19 PCR testinin ameliyat öncesi rutin uygulamasının sonuçlarda herhangi bir istatistiksel değişikliğe neden olmadığı görüldü

🔖

Cite This Article

ARAS, O., GÖMCELİ, İ., YAVUZ, R. (2022). Age of Pandemics: WillWe Be Ableto Perform Gastrointestinal Cancer Surgical Treatments in Future Pandemics? What have we Learned from the COVID-19 Pandemic in Our Country, Which is one of the Developing Countries?. Kocaeli Tıp Dergisi, Cilt: 10 - Sayı: Ek 1, 103–111. https://ajindex.com/articles/652947

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Lu H, Stratton CW, Tang YW. (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 92(4):401–2. doi: 10.1002/jmv.25678. 2. Rothan HA, Byrareddy SN. (2020) The epidemiology and pathogenesis of coronavirus disease ( O I -19) outbrea. J Autoimmun. 109:102433. 3. Tian Y, Rong L, Nian W, He Y. (2020) Reviewarticle: gastrointestinal features in COVID19 and the possibility of faecal transmission. Aliment Pharmacol Ther 51(9): 843-51. 4. Highleyman L. Cancer Patients With COVID-19 May Have Higher Risk of Severe Illness and Death Cancer Health. [Accessed Jun 10 2020].Available at:https://www.cancerhealth.com/ article/cancer-patients-covid19-may-higher-risksevere-illness-death. 5. Mengyuan Dai, Dianbo Liu, Miao Liu et al. (2020) Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak Cancer Discov. Jun; 10(6): 783–91. doi: 10.1158/2159-8290.CD20-0422 6. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. (2020) Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China. Lancet Oncol. 21:335–7. doi.org/10.1016/S1470- 2045(20)30096-6 7. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–32. 8. COVID 19: Elective Case Triage Guidelines for Surgical Care Cancer From the American College of Surgeons Online March 24, 2020 https://www.facs.org/covid-19/clinicalguidance/elective-case/cancer-surgery 9. Aurora P. Sages and Eaes Recommendatıons Regardıng Surgıcal Response to COVID-19 Crisis https://www.sages.org/recommendations-surgical response-covid-19/ (accessed 3 April 2020). 10. COVID Surg Collaborative: Elective surgery cancellations due to the COVID-19 pandemic: Global predictive modelling to inform surgical recovery plans. Br J Surg 10.1002/bjs.11746 [epubahead of print on May 12, 2020] 11. NHS England and NHS Improvement: Advice to trusts on maintaining cancer treatment during the COVID-19 response, 2020 https://www.england.nhs.uk/coronavirus/publicatio n/advice-to-trusts-on-maintaining-cancer-treatmentduring-the-covid-19-response 12. Sud A, Jones M, Broggio J, et al: Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer, 2020. https://www.medrxiv.org/content/ 10.1101/2020.04.28.20083170v1 13. British Association for Cancer Surgery: BASO guidance–strategy for cancer surgery sustainability and recovery in the COVID 19 pandemic, 2020. 14.